| Literature DB >> 26974246 |
Troy A McEachron1,2, Leonard S Sender2,3,4,5, Keri B Zabokrtsky2,3, Brian Kaltenecker6, W Nathan Holmes7, Irene Cherni1, Zarko Manojlovic1, Shu-Yuan Liao8,9, David W Craig10, John D Carpten1, Lilibeth R Torno2,5.
Abstract
Glassy cell carcinoma of the cervix (GCCC) is a very rare and aggressive form of cervical cancer. An adolescent female with advanced metastatic disease was enrolled in our genomic profiling research protocol. We identified high-level amplification of epidermal growth factor receptor (EGFR) and Yes-associated protein-1 (YAP1), which led to the addition of EGFR inhibitors to the chemotherapy regimen. Here, we report the first genetically profiled case of GCCC with potential therapeutic implications.Entities:
Keywords: carcinoma; cervical cancer; chemotherapy; gene regulation; imaging; treatment
Mesh:
Substances:
Year: 2016 PMID: 26974246 DOI: 10.1089/jayao.2015.0068
Source DB: PubMed Journal: J Adolesc Young Adult Oncol ISSN: 2156-5333 Impact factor: 2.223